KHB(SZ:002022)2022-12-06 01:34Group 1: Company Overview and Performance - The company, Shanghai Kehua Bio-engineering Co., Ltd., reported a revenue of 90 million from export business in 2014, aiming to restore and exceed this level in the future [3] - The company has made significant improvements in its operational performance in the first half of 2016 compared to the previous year, particularly in the biochemical business, which exceeded market expectations [4] - The company has integrated its marketing team and optimized market strategies, contributing positively to performance [4] Group 2: Export Business and WHO Approval - The company has faced delays in the WHO approval process for its export business, which is currently being actively pursued [3] - The company has completed necessary preparations for WHO approval, including on-site verification and submission of relevant materials [3] Group 3: Blood Screening Business - The blood screening business has shown substantial growth, covering 15 provinces and over 60 terminal points, including 11 provincial blood centers [3] - The company expects stable and sustainable growth in the blood screening market due to ongoing demand and successful bidding results [3] Group 4: Product Development and Acquisitions - The company has launched its self-developed chemiluminescence instruments and aims to achieve market penetration within two years [4] - The acquisition of TGS was driven by its advanced R&D platform and technology, which is expected to enhance the company's product line and market presence [5] - The company is exploring opportunities for external acquisitions, focusing on IVD-related fields and potential growth areas [5] Group 5: Future Strategies - The company plans to extend its business model from "instruments + reagents" to service-oriented approaches, enhancing sales through increased influence on end-users [6] - The company has signed a cooperation agreement with BDI to develop microfluidic and chemiluminescence technologies for POCT projects, aiming to enhance product competitiveness [5]